| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S10038-006-0090-5 |
| P698 | PubMed publication ID | 17143591 |
| P2093 | author name string | Yusuke Nakamura | |
| Atsunori Kashiwagi | |||
| Shiro Maeda | |||
| Tatsuhiko Tsunoda | |||
| Daisuke Koya | |||
| Takashi Uzu | |||
| Shin-ichi Araki | |||
| Norihisa Osawa | |||
| P2860 | cites work | Association of the gene encoding wingless-type mammary tumor virus integration-site family member 5B (WNT5B) with type 2 diabetes | Q24534095 |
| Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy | Q29615215 | ||
| A unified stepwise regression procedure for evaluating the relative effects of polymorphisms within a gene using case/control or family data: application to HLA in type 1 diabetes | Q30665913 | ||
| Role of angiotensin II in diabetic nephropathy. | Q34039750 | ||
| Association between a single-nucleotide polymorphism in the promoter of the human interleukin-3 gene and rheumatoid arthritis in Japanese patients, and maximum-likelihood estimation of combinatorial effect that two genetic loci have on susceptibilit | Q34113270 | ||
| Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells | Q34150690 | ||
| Mechanisms of diabetic vasculopathy: an overview. | Q34258094 | ||
| An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels | Q34262228 | ||
| Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group | Q37365616 | ||
| Genetic variation in the Renin-Angiotensin system and progression of diabetic nephropathy | Q40554813 | ||
| Angiotensin-converting enzyme (ACE) I/D genotype and renal ACE gene expression | Q44152987 | ||
| Molecular basis of human hypertension: role of angiotensinogen | Q45118696 | ||
| Gender-specific association of M235T polymorphism in angiotensinogen gene and diabetic nephropathy in NIDDM. | Q50897511 | ||
| A high-throughput SNP typing system for genome-wide association studies | Q57269468 | ||
| Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction | Q57606113 | ||
| Angiotensin-I converting enzyme insertion/deletion polymorphism and its association with diabetic nephropathy: a meta-analysis of studies reported between 1994 and 2004 and comprising 14,727 subjects | Q61771206 | ||
| The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group | Q70513402 | ||
| Angiotensinogen M235T and chymase gene CMA/B polymorphisms are not associated with nephropathy in type II diabetes | Q73235838 | ||
| Hypertension management in adults with diabetes | Q75205682 | ||
| Angiotensin I-converting enzyme gene polymorphisms: relationship to nephropathy in patients with non-insulin dependent diabetes mellitus | Q77197593 | ||
| Angiotensin II induces superoxide anion production by mesangial cells | Q77291532 | ||
| Polymorphisms of angiotensin converting enzyme and plasminogen activator inhibitor-1 genes in diabetes and macroangiopathy1 | Q77650677 | ||
| Relationship between polymorphism in the angiotensinogen, angiotensin-converting enzyme or angiotensin II receptor and renal progression in Japanese NIDDM patients | Q77867095 | ||
| Relationship between polymorphisms in the renin-angiotensin system and nephropathy in type 2 diabetic patients | Q77893800 | ||
| P433 | issue | 2 | |
| P921 | main subject | diabetic nephropathy | Q1129105 |
| P304 | page(s) | 143-151 | |
| P577 | publication date | 2006-12-02 | |
| P1433 | published in | Journal of Human Genetics | Q6295302 |
| P1476 | title | Combinational effect of genes for the renin-angiotensin system in conferring susceptibility to diabetic nephropathy | |
| P478 | volume | 52 |
| Q63440925 | ACACβ gene (rs2268388) and AGTR1 gene (rs5186) polymorphism and the risk of nephropathy in Asian Indian patients with type 2 diabetes |
| Q30486653 | ACE insertion/deletion (I/D) polymorphism and diabetic nephropathy. |
| Q37415982 | Angiotensin II type 1 receptor 1166C polymorphism is associated with abdominal aortic aneurysm in three independent cohorts |
| Q36063285 | Angiotensin converting enzyme insertion/deletion polymorphism and renoprotection in diabetic and nondiabetic nephropathies |
| Q41598169 | Angiotensinogen (AGT) gene missense polymorphisms (rs699 and rs4762) and diabetic nephropathy in Caucasians with type 2 diabetes mellitus |
| Q84183306 | Association between two genetic polymorphisms of the renin-angiotensin-aldosterone system and diabetic nephropathy: a meta-analysis |
| Q30433474 | Associations between genetic variants in the ACE, AGT, AGTR1 and AGTR2 genes and renal function in the Multi-ethnic Study of Atherosclerosis |
| Q39925169 | Effects of Common Polymorphisms in the MTHFR and ACE Genes on Diabetic Peripheral Neuropathy Progression: a Meta-Analysis |
| Q34098493 | Endothelial Nitric Oxide Synthase Gene Variation Associated With Chronic Kidney Disease After Liver Transplant |
| Q35028043 | Genetic Predisposition to Diabetic Nephropathy: Evidence for a Role of ACE (I/D) Gene Polymorphism in Type 2 Diabetic Population from Kutch Region |
| Q38527798 | Identifying Common Genetic Risk Factors of Diabetic Neuropathies |
| Q37590421 | The genetics of diabetic nephropathy. |
Search more.